Literature DB >> 15865076

Comparison of ante- and post-mortem PSA levels for epidemiological studies.

Richard F Jones1, Robert Sunheimer, Henry Friedman, David Miller, Ronald Ginsburg, Mary Jumbelic, Gregory Threatte, Gabriel P Haas.   

Abstract

BACKGROUND: Valuable correlations could be made between serum prostate specific antigen (PSA) and prostate histopathology by the use of autopsy sampling if post-mortem PSA data were informative. However, PSA forms and levels in autopsy sera have not been investigated.
MATERIALS AND METHODS: Paired ante- and post-mortem sera were collected for a series of cases. Total and free PSA levels in each were determined and compared. These PSA data were correlated with corresponding changes in serum electrolyte levels.
RESULTS: Total PSA levels were similar in ante- and post-mortem sera if autopsy blood was drawn by approximately 24 hours following the time of death. Free PSA levels, however, were increased approximately two-fold in most post-mortem sera analyzed. Increases in the serum electrolytes potassium, magnesium and phosphate correlated positively with increases in free PSA.
CONCLUSION: Total PSA levels in ante- and post-mortem sera were comparable. Free PSA levels had approximately doubled by autopsy, but may be normalized in relation to increases in serum electrolyte levels. The use of autopsy prostates and PSA data would avoid diagnostic bias from use of clinical material and permit extensive analysis to be carried out, which is not normally feasible with live subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15865076

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

2.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

3.  Relationship between serum prostate-specific antigen and age in cadavers.

Authors:  Hajime Tsuboi; Daisuke Miyamori; Noboru Ishikawa; Hiroaki Ichioka; Hiroshi Ikegaya
Journal:  SAGE Open Med       Date:  2020-09-16

4.  Association of prostate cancer and manganese superoxide dismutase AA genotype influenced by presence of occult cancer in control group.

Authors:  Taro Iguchi; Ching Y Wang; Nicolas B Delongchamps; Robert Sunheimer; Tatsuya Nakatani; Gustavo de la Roza; Gabriel P Haas
Journal:  Urology       Date:  2008-06-24       Impact factor: 2.649

5.  Occult prostate cancer effects the results of case-control studies due to verification bias.

Authors:  Taro Iguchi; Ching Y Wang; Nicolas B Delongchamps; Robert Sunheimer; Tatsuya Nakatani; Gustavo de la Roza; Gabriel P Haas
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.